-
Product Insights
Likelihood of Approval Analysis for Menopausal Disorders
Overview How likely is it that the drugs in Menopausal Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Menopausal Disorders Overview Menopausal disorders encompass a range of symptoms and health...
-
Product Insights
Likelihood of Approval Analysis for Post Partum Depression (Maternal Depression / Postnatal Depression)
Overview How likely is it that the drugs in Post Partum Depression (Maternal Depression / Postnatal Depression) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Post Partum Depression (Maternal Depression /...
-
Product Insights
Likelihood of Approval Analysis for Primary Progressive Multiple Sclerosis (PPMS)
Overview How likely is it that the drugs in Primary Progressive Multiple Sclerosis (PPMS) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Primary Progressive Multiple Sclerosis (PPMS) Overview Primary progressive multiple...
-
Product Insights
Likelihood of Approval Analysis for Papillary Thyroid Cancer
Overview How likely is it that the drugs in Papillary Thyroid Cancer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Papillary Thyroid Cancer Overview Papillary thyroid cancer (PTC) is the most...
-
Company Insights
John Lewis – Digital Transformation Strategies
John Lewis Digital Transformation Strategies Overview John Lewis has been focusing on using AI, big data, cloud, robotics, contactless retail, innovation, digital twin, gaming, electric vehicles, and e-commerce to digitally transform its operations. The annual ICT spending of John Lewis was estimated at $297.9 million for 2023. A major share of this spending is earmarked for acquiring software, network and communications, and ICT services from vendors. John Lewis, the principal trading subsidiary of John Lewis Partnership Plc, owns and operates...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Palbociclib in Metastatic Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Palbociclib in Metastatic Breast Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Palbociclib in Metastatic Breast Cancer Drug Details: Palbociclib (Ibrance, Agatha)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Palbociclib in Chordoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Palbociclib in Chordoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Palbociclib in Chordoma Drug Details: Palbociclib (Ibrance, Agatha) is a pyridopyrimidine-derived cyclin-dependent...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Palbociclib in Nonmelanomatous Skin Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Palbociclib in Nonmelanomatous Skin Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Palbociclib in Nonmelanomatous Skin Cancer Drug Details: Palbociclib (Ibrance, Agatha) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Palbociclib in Liposarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Palbociclib in Liposarcoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Palbociclib in Liposarcoma Drug Details: Palbociclib (Ibrance, Agatha) is a pyridopyrimidine-derived cyclin-dependent kinase...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Palbociclib in Cervical Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Palbociclib in Cervical Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Palbociclib in Cervical Cancer Drug Details: Palbociclib (Ibrance, Agatha) is a...